These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37901864)

  • 1. A biomarker and molecular mechanism investigation for thyroid cancer.
    Xie K
    Cent Eur J Immunol; 2023; 48(3):203-218. PubMed ID: 37901864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF10 and IDO1 as a thyroid cancer prognostic biomarker associated with immune infiltration.
    Lv ZB; Zhang JJ; Xiang C
    Heliyon; 2024 Mar; 10(6):e27651. PubMed ID: 38509876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma.
    Xie Y; Xiao J; Ying Y; Liu J; Zhang L; Zeng X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5663-5676. PubMed ID: 38289368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
    Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
    Front Genet; 2021; 12():744304. PubMed ID: 34976004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration.
    Wu L; Zhou Y; Guan Y; Xiao R; Cai J; Chen W; Zheng M; Sun K; Chen C; Huang G; Zhang X; Qian Z; Shen S
    Front Oncol; 2021; 11():756246. PubMed ID: 35141140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable Prognostic Impact of Cathepsin H (CTSH) High Expression in Thyroid Carcinoma.
    Peng P; Chen JY; Zheng K; Hu CH; Han YT
    Int J Gen Med; 2021; 14():5287-5299. PubMed ID: 34522128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
    Shuwen H; Xi Y; Miao D; Jiamin X; Jing Z; Weili G
    Dis Markers; 2020; 2020():9369341. PubMed ID: 32626543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis.
    Pan H; Luo Z; Lin F; Zhang J; Xiong T; Hong Y; Sun B; Yang Y
    Oncol Lett; 2024 Nov; 28(5):510. PubMed ID: 39268167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway.
    Chen C; Shen Z
    Protein Pept Lett; 2023; 30(1):54-64. PubMed ID: 36278453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
    Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
    J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
    Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
    BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
    Lu JC; Zhang YP
    Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of ferroptosis-related hub genes in obstructive sleep apnea syndrome.
    Liu P; Zhao D; Pan Z; Tang W; Chen H; Hu K
    Front Neurol; 2023; 14():1130378. PubMed ID: 36937508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer.
    Geng QS; Huang T; Li LF; Shen ZB; Xue WH; Zhao J
    Front Med (Lausanne); 2021; 8():812278. PubMed ID: 35141255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Prognosis-Associated Biomarkers in Thyroid Carcinoma by a Bioinformatics Analysis.
    Qin Y
    Int J Gen Med; 2021; 14():5737-5747. PubMed ID: 34557027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.